News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Daily News Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence L.A. McKeown December 09, 2022
News Daily News Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs L.A. McKeown December 08, 2022
News Daily News FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential L.A. McKeown December 06, 2022
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Daily News Many STEMI Patients Not Treated Within National Time Goals Michael O'Riordan November 15, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News AHA 2022 ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD Shelley Wood November 06, 2022
News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Conference News VIVA 2022 ‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups L.A. McKeown November 04, 2022
News Daily News Race and Sex Dictate Publication Rate for Med Students Yael L. Maxwell October 26, 2022
News Daily News New Biomarker-Based Risk Score Performs Well in ACS Michael O'Riordan October 25, 2022
News Features From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine L.A. McKeown October 18, 2022
News Daily News Risk of Radiation Low for Pregnant Operators When Precautions Taken Michael O'Riordan September 27, 2022
News Conference News TCT 2022 RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion Todd Neale September 21, 2022
News Conference News TCT 2022 Dedicated Catheter for Acute PE Shows Promise in IDE Trial L.A. McKeown September 17, 2022
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022